Tirzepatide SURMOUNT-1 (2022) and SURPASS-2 (2021) SURMOUNT-1 (Jastreboff et al., NEJM 2022): 2,539 non-diabetic adults with BMI 30, 72 weeks of tirzepatide 15 mg/week: Weight loss: 20.9% (vs 3.1% placebo) 91% of participants 5% loss, 56.7% 20% SURPASS-2 (Fras et al., NEJM 2021): 1,879 T2D patients head-to-head vs semaglutide 1 mg: HbA1c: 2.30% (tirzepatide 15 mg) vs 1.86% (semaglutide) Weight loss: 11.2 kg vs 5.7 kg Tirzepatide statistically outperforms semaglutide on both HbA1c and weight in a head-to-head trial a rare outcome in incretin pharmacology
Vitamin B12 Injections and Infusions in NYC Being nutrient deficient can cause a myriad of physical and mental health problems that are easy to resolve
In our experience, scalp lesions have intraepidermal epithelioid cell nests that are finely pigmented and have similar cells in the papillary dermis that are often mistaken for microinvasive melanoma
Proper peptide storage and handling prove essential, with lyophilized peptides requiring storage at -20C or lower (optimally -80C) away from bright light and moisture, and peptides containing cysteine, methionine, or tryptophan requiring additional protection from oxidation through anaerobic storage conditions to maintain stability and biological activity throughout experimental protocols
.png)
